https://doi.org/10.1186/gb-2009-10-6-r64
F
Frank Speleman
Ghent University(BE)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
811
Papers
26.0K
Citations
83
h-index
272
i10-index
Frank Speleman is an academic researcher from Ghent University. The author has contributed to research in topics: Neuroblastoma Research and Treatments & Cancer, Hypoxia, and Metabolism & Protein Degradation and Inhibitors. The author has an h-index of 83, co-authored 690 publications.
ORCID: 0000-0002-6628-8559Papers by this author
worksA novel and universal method for microRNA RT-qPCR data normalization
2009 · Genome biology · 1,014 citations
Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes
2006 · Genome biology · 163 citations
https://doi.org/10.1186/gb-2006-7-9-r84
MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival
2011 · Cell Death and Differentiation · 153 citations
https://doi.org/10.1038/cdd.2010.164
A Novel Gene Family NBPF: Intricate Structure Generated by Gene Duplications During Primate Evolution
2005 · Molecular Biology and Evolution · 152 citations
https://doi.org/10.1093/molbev/msi222
A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies
2014 · Oncogene · 145 citations
https://doi.org/10.1038/onc.2014.269
Antitumor Activity of the Selective MDM2 Antagonist Nutlin-3 Against Chemoresistant Neuroblastoma With Wild-Type p53
2009 · JNCI Journal of the National Cancer Institute · 120 citations
https://doi.org/10.1093/jnci/djp355
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat